Cargando…
TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice
Accumulating evidence shows that brain-derived neurotrophic factor (BDNF) and its receptor tropomyosin-related kinase B (TrkB) significantly decrease early in Alzheimer's disease (AD). However, it remains unclear whether BDNF/TrkB reductions may be mechanistically involved in the pathogenesis o...
Autores principales: | Devi, L, Ohno, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471286/ https://www.ncbi.nlm.nih.gov/pubmed/25942043 http://dx.doi.org/10.1038/tp.2015.55 |
Ejemplares similares
-
An Ultra-Low Dose of ∆9-Tetrahydrocannabinol Alleviates Alzheimer’s Disease-Related Cognitive Impairments and Modulates TrkB Receptor Expression in a 5XFAD Mouse Model
por: Nitzan, Keren, et al.
Publicado: (2022) -
Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease
por: Wang, Shudan, et al.
Publicado: (2020) -
Imbalance of neurotrophin receptor isoforms TrkB-FL/TrkB-T1 induces neuronal death in excitotoxicity
por: Vidaurre, Ó G, et al.
Publicado: (2012) -
Do Small Molecules Activate the TrkB Receptor in the Same Manner as BDNF? Limitations of Published TrkB Low Molecular Agonists and Screening for Novel TrkB Orthosteric Agonists
por: Pankiewicz, Piotr, et al.
Publicado: (2021) -
TrkB-Targeted Therapy for Mucoepidermoid Carcinoma
por: Wagner, Vivian P., et al.
Publicado: (2020)